Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer

NCT01302834 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

987

Enrollment

NETWORK

Sponsor class

Conditions

Head and Neck Cancer
Precancerous Condition

Interventions

BIOLOGICAL: cetuximab
DRUG: cisplatin
RADIATION: IMRT

Sponsor

Radiation Therapy Oncology Group

Collaborators

[object Object]
[object Object]